Efficacy and Safety Study of Oxypurinol Added to Standard Therapy in Patients with New York Heart Association Class III-IV Congestive Heart Failure (The OPT-CHF Trial)

Authors

Ronald S. Freudenberger MD, Lehigh Valley Health NetworkFollow

Publication/Presentation Date

12-2006

Volume

12

Issue

9

First Page

764

Last Page

764

Published In/Presented At

https://doi.org/10.1016/j.cardfail.2006.10.009

Disciplines

Medicine and Health Sciences

Department(s)

Cardiology Division

Document Type

Article